The total pharmaceutical market in Thailand was valued at 17.09 billion baht ($680.1 million) for 1993, an increase of 10.5% over the previous year, according to the latest figures issued by the Pharmaceutical Producers Association of Thailand. Growth through the period from 1987 has been above 10% annually.
In terms of therapeutic categories, the largest was anti-infectives, the PPA says, accounting for 21.1% of the market, as shown in the table below.
Leading Categories Market Share Anti-infectives 21.1% Alimentary system drugs 16.1% Respiratory system products 12.1% Cardiovasculars 8.6% Central nervous system drugs 8.1% Musculoskeletal drugs 6.8% Dermatologicals 6.5% Hospital solutions 4.1% Blood products 3.5% Genitourinary, sex hormones 3.0% Cytostatics 2.1% Sensory organ drugs 1.9% Systemic hormones 1.4% Parasitics 0.7% Various 4.0%
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze